UK markets closed

Lotus Pharmaceuticals, Inc. (LTUS)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.00500.0000 (0.00%)
As of 10:06AM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 762.17k
Enterprise value 762.17k
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.02
Price/book (mrq)0.01
Enterprise value/revenue 0.01
Enterprise value/EBITDA 0.20

Trading information

Stock price history

Beta (5Y monthly) -0.39
52-week change 3-50.00%
S&P500 52-week change 322.38%
52-week high 30.0120
52-week low 30.0035
50-day moving average 30.0053
200-day moving average 30.0054

Share statistics

Avg vol (3-month) 35.22k
Avg vol (10-day) 34.98k
Shares outstanding 527.82M
Implied shares outstanding 6166.9M
Float 8N/A
% held by insiders 10.00%
% held by institutions 10.00%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:2
Last split date 331 Dec 2010

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2010
Most-recent quarter (mrq)30 Sept 2011

Profitability

Profit margin 2.43%
Operating margin (ttm)6.66%

Management effectiveness

Return on assets (ttm)4.56%
Return on equity (ttm)1.82%

Income statement

Revenue (ttm)71.39M
Revenue per share (ttm)2.60
Quarterly revenue growth (yoy)4.00%
Gross profit (ttm)N/A
EBITDA 10.31M
Net income avi to common (ttm)1.72M
Diluted EPS (ttm)-0.0400
Quarterly earnings growth (yoy)-81.30%

Balance sheet

Total cash (mrq)158.91k
Total cash per share (mrq)0.01
Total debt (mrq)6.18M
Total debt/equity (mrq)6.22%
Current ratio (mrq)0.53
Book value per share (mrq)3.58

Cash flow statement

Operating cash flow (ttm)18.37M
Levered free cash flow (ttm)-5.29M